Inherited secondary nephrogenic diabetes insipidus: Concentrating on humans

American Journal of Physiology - Renal Physiology

Volumn 304, Issue 8, 2013, Pages 1037-1042

  Bockenhauer, D ^a   Bichet, D G ^b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Apparent mineralocorticoid excess; Bartter syndrome; Cystinosis; Hypercalciuria; Hypo kalemia; Nephrogenic diabetes insipidus; Nephronophthisis; Renal fanconi syndrome

Indexed keywords

AQUAPORIN 2;

ABNORMAL LABORATORY RESULT; APPARENT MINERALOCORTICOID EXCESS SYNDROME; BARTTER SYNDROME; CHEMICAL ANALYSIS; CILIARY DYSKINESIA; DISEASE ASSOCIATION; FANCONI RENOTUBULAR SYNDROME; GENETIC DISORDER; HUMAN; HYPERCALCIURIA; HYPOKALEMIA; HYPOMAGNESEMIA; KIDNEY CALCIFICATION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE ACIDOSIS; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 84878658218     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00639.2012     Document Type: Review

References (68)

1. Anadoliiska A, Roussinov D. Clinical aspects of renal involvement in Bardet-Biedl syndrome. Int Urol Nephrol 25: 509-514, 1993.
2. Bergsland KJ, Coe FL, Gillen DL, Worcester EM. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol 297: F1017-F1023, 2009.
3. Bettinelli A, Ciarmatori S, Cesareo L, Tedeschi S, Ruffa G, Appiani AC, Rosini A, Grumieri G, Mercuri B, Sacco M, Leozappa G, Binda S, Cecconi M, Navone C, Curcio C, Syren ML, Casari G. Phenotypic variability in Bartter syndrome type I. Pediatr Nephrol 14: 940-945, 2000.
4. Bichet DG. Nephrogenic diabetes insipidus. Semin Nephrol 14: 349-356, 1994.
5. Bockenhauer D. Diabetes insipidus. In: Comprehensive Pediatric Nephrology, edited by Geary DF and Schaefer F. Philadelphia, PA: Mosby Elsevier, 2008, p. 489-498.
6. Bockenhauer D, Bokenkamp A, van't Hoff W, Levtchenko E, Kist-van Holthe JE, Tasic V, Ludwig M. Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction. Clin J Am Soc Nephrol 3: 1430-1436, 2008.
7. Bockenhauer D, Carpentier E, Rochdi D, Van't Hoff W, Breton B, Bernier V, Bouvier M, Bichet DG. Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus. Nephron Physiol 114: p1-p10, 2009.
8. Bockenhauer D, Cruwys M, Kleta R, Halperin LF, Wildgoose P, Souma T, Nukiwa N, Cheema-Dhadli S, Chong CK, Kamel KS, Davids MR, Halperin ML. Antenatal Bartter's syndrome: why is this not a lethal condition? QJM 101: 927-942, 2008.
9. Bockenhauer D, Medlar AJ, Ashton E, Kleta R, Lench N. Genetic testing in renal disease. Pediatr Nephrol 27: 873-883, 2012.
10. Bockenhauer D, Rees L, van't Hoff W. An association of tubular dysfunction, cortical macrocysts and chronic kidney disease. Pediatr Nephrol 21: 580-583, 2006.
11. Bockenhauer D, van't Hoff W. Fanconi Syndrome. In: Comprehensive Pediatric Nephrology, edited by Geary DF and Schaefer F. Philadelphia, PA: Mosby Elsevier, 2008, p. 433-450.
12. Bockenhauer D, van't Hoff W, Dattani M, Lehnhardt A, Subtirelu M, Hildebrandt F, Bichet DG. Secondary nephrogenic diabetes insipidus as a complication of inherited renal diseases. Nephron Physiol 116: p23-p29, 2010.
13. Bokenkamp A, Ludwig M. Disorders of the renal proximal tubule. Nephron Physiol 118: p1-p6, 2011.
14. Brochard K, Boyer O, Blanchard A, Loirat C, Niaudet P, Macher MA, Deschenes G, Bensman A, Decramer S, Cochat P, Morin D, Broux F, Caillez M, Guyot C, Novo R, Jeunemaitre X, Vargas-Poussou R. Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome. Nephrol Dial Transplant 24: 1455-1464, 2009.
15. 2+ on renal function? J Am Soc Nephrol 6: 1530-1540, 1995.
16. Bustamante M, Hasler U, Leroy V, de Seigneux S, Dimitrov M, Mordasini D, Rousselot M, Martin PY, Feraille E. Calcium-sensing receptor attenuates AVP-induced aquaporin-2 expression via a calmodu-lin-dependent mechanism. J Am Soc Nephrol 19: 109-116, 2008.
17. Cooper M, Stewart PM. The syndrome of apparent mineralocorticoid excess. QJM 91: 453-455, 1998.
18. Dalgaard OZ. Bilateral polycystic disease of the kidneys; a follow-up of 284 patients and their families. Dan Med Bull 4: 128-133, 1957.
19. Deen PM, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, van Os CH, van Oost BA. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264: 92-95, 1994.
20. Eastham KM, McKiernan PJ, Milford DV, Ramani P, Wyllie J, van't Hoff W, Lynch SA, Morris AA. ARC syndrome: an expanding range of phenotypes. Arch Dis Child 85: 415-420, 2001.
21. Evans LC, Livingstone DE, Kenyon CJ, Jansen MA, Dear JW, Mullins JJ, Bailey MA. A urine-concentrating defect in 11 β-hydroxys-teroid dehydrogenase type 2 null mice. Am J Physiol Renal Physiol 303: F494-F502, 2012.
22. Fick GM, Duley IT, Johnson AM, Strain JD, Manco-Johnson ML, Gabow PA. The spectrum of autosomal dominant polycystic kidney disease in children. J Am Soc Nephrol 4: 1654-1660, 1994.
23. Folami AO, Balfe JW, Robson WL, Halperin ML, Stinebaugh BJ. Coexistence of distal renal tubular acidosis and nephrogenic diabetes insipidus in two patients: implications for the pathogenesis of distal renal tubular acidosis. Clin Invest Med 1: 105-109, 1978.
24. Fujiwara TM, Bichet DG. Molecular biology of hereditary diabetes insipidus. J Am Soc Nephrol 16: 2836-2846, 2005.
25. Fushimi K, Uchida S, Hara Y, Hirata Y, Marumo F, Sasaki S. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature 361: 549-552, 1993.
26. Gabow PA, Kaehny WD, Johnson AM, Duley IT, Manco-Johnson M, Lezotte DC, Schrier RW. The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int 35: 675-680, 1989.
27. Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, Wang NS, Knepper MA. Large-scale proteomics and phosphopro-teomics of urinary exosomes. J Am Soc Nephrol 20: 363-379, 2009.
28. Haisch L, Konrad M. Impaired paracellular ion transport in the loop of Henle causes familial hypomagnesemia with hypercalciuria and nephro-calcinosis. Ann NY Acad Sci 1258: 177-184, 2012.
29. 2+-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 200: 295-302, 1997.
30. Hildebrandt F, Omram H. New insights: nephronophthisis-medullary cystic kidney disease. Pediatr Nephrol 16: 168-176, 2001.
31. 2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J Clin Invest 112: 1906-1914, 2003.
32. Holliday MA, Egan TJ, Morris CR, Jarrah AS, Harrah JL. Pitressin-resistant hyposthenuria in chronic renal disease. Am J Med 42: 378-387, 1967.
33. Imhoff O, Marion V, Stoetzel C, Durand M, Holder M, Sigaudy S, Sarda P, Hamel CP, Brandt C, Dollfus H, Moulin B. Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort. Clin J Am Soc Nephrol 6: 22-29, 2011.
34. Jang JY, Kim KM, Kim GH, Yu E, Lee JJ, Park YS, Yoo HW. Clinical characteristics and VPS33B mutations in patients with ARC syndrome. J Pediatr Gastroenterol Nutr 48: 348-354, 2009.
35. Karet FE. Disorders of water and acid-base homeostasis. Nephron Physiol 118: p28-p34, 2011.
36. Katzir Z, Shvil Y, Landau H, Kidrony G, Popovtzer MM. Nephrogenic diabetes insipidus, cystinosis, and vitamin D. Arch Dis Child 63: 548-550, 1988.
37. Kleta R. Fanconi or not Fanconi? Lowe syndrome revisited. Clin J Am Soc Nephrol 3: 1244-1245, 2008.
38. Kleta R, Bockenhauer D. Bartter syndromes and other salt-losing tubu-lopathies. Nephron Physiol 104: p73-p80, 2006.
39. Knoepfelmacher M, Rocha R, Salgado LR, Semer M, Voss D, Wa-jchenberg BL, Liberman B. [Nephropathic cystinosis: report of 2 cases and review of the literature]. Rev Assoc Med Bras 40: 43-46, 1994.
40. Lam GS, Asplin JR, Halperin ML. Does a high concentration of calcium in the urine cause an important renal concentrating defect in human subjects? Clin Sci (Lond) 98: 313-319, 2000.
41. Lemire J, Kaplan BS. The various renal manifestations of the nephropathic form of cystinosis. Am J Nephrol 4: 81-85, 1984.
42. Lolait SJ, O'Carroll AM, McBride OW, Konig M, Morel A, Brown-stein MJ. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357: 336-339, 1992.
43. Malaki M, Mandana R, Ghaffari S. ARC syndrome with complex renal problems: nephrocalcinosis, proximal and hyperkalemic distal RTA and nephrogenic diabetes insipidus. Saudi J Kidney Dis Transplant 23: 804-809, 2012.
44. Marion V, Schlicht D, Mockel A, Caillard S, Imhoff O, Stoetzel C, van Dijk P, Brandt C, Moulin B, Dollfus H. Bardet-Biedl syndrome highlights the major role of the primary cilium in efficient water reabsorption. Kidney Int 79: 1013-1025, 2011.
45. Marples D, Frokiaer J, Dorup J, Knepper MA, Nielsen S. Hypokal-emia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest 97: 1960-1968, 1996.
46. Marples D, Frokiaer J, Knepper MA, Nielsen S. Disordered water channel expression and distribution in acquired nephrogenic diabetes insipidus. Proc Assoc Am Physicians 110: 401-406, 1998.
47. Marx SJ, Attie MF, Stock JL, Spiegel AM, Levine MA. Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab 52: 736-740, 1981.
48. McIlraith CH. Notes on some cases of diabetes insipidus with marked family and hereditary tendencies. Lancet 2: 767, 1892.
49. Milford DV, Shackleton CH, Stewart PM. Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess. Clin Endocrinol (Oxf) 43: 241-246, 1995.
50. Nielsen J, Kwon TH, Christensen BM, Frokiaer J, Nielsen S. Dysregu-lation of renal aquaporins and epithelial sodium channel in lithium-induced nephrogenic diabetes insipidus. Semin Nephrol 28: 227-244, 2008.
51. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82: 205-244, 2002.
52. Olesen ET, Rutzler MR, Moeller HB, Praetorius HA, Fenton RA. Vasopressin-independent targeting of aquaporin-2 by selective E-prostan-oid receptor agonists alleviates nephrogenic diabetes insipidus. Proc Natl Acad Sci USA 108: 12949-12954, 2011.
53. Pan Y, Metzenberg A, Das S, Jing B, Gitschier J. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet 2: 103-106, 1992.
54. Peters M, Jeck N, Reinalter S, Leonhardt A, Tonshoff B, Klaus GG, Konrad M, Seyberth HW. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 112: 183-190, 2002.
55. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297-1303, 1993.
56. Praga M, Vara J, Gonzalez-Parra E, Andres A, Alamo C, Araque A, Ortiz A, Rodicio JL. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47: 1419-1425, 1995.
57. Procino G, Mastrofrancesco L, Tamma G, Lasorsa DR, Ranieri M, Stringini G, Emma F, Svelto M, Valenti G. Calcium-sensing receptor and aquaporin 2 interplay in hypercalciuria-associated renal concentrating defect in humans. An in vivo and in vitro study. PLoS ONE 7: e33145, 2012.
58. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, Birnbaumer M, Bichet DG. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359: 233-235, 1992.
59. Seyberth HW. An improved terminology and classification of Bartter-like syndromes. Nat Clin Pract Nephrol 4: 560-567, 2008.
60. Shearn MA, Tu WH. Nephrogenic diabetic insipidus and other defects of renal tubular function in Sjoergren's Syndrome. Am J Med 39: 312-318, 1965.
61. Singer I. Lithium and the kidney. Kidney Int 19: 374-387, 1981.
62. Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Shep-pard MC, Whorwood CB. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet 347: 88-91, 1996.
63. Tolaymat A, Sakarcan A, Neiberger R. Idiopathic Fanconi syndrome in a family. Part I. Clinical aspects. J Am Soc Nephrol 2: 1310-1317, 1992.
64. van den Ouweland AM, Dreesen JC, Verdijk M, Knoers NV, Mon-nens LA, Rocchi M, van Oost BA. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet 2: 99-102, 1992.
65. Vivante A, Lotan D, Pode-Shakked N, Landau D, Svec P, Nam-poothiri S, Verma I, Abu-Libdeh A, Bockenhauer D, Dekel B, An-ikster Y. Familial autosomal recessive renal tubular acidosis: importance of early diagnosis. Nephron Physiol 119: p31-p39, 2011.
66. Wilson RC, Nimkarn S, New MI. Apparent mineralocorticoid excess. Trends Endocrinol Metab 12: 104-111, 2001.
67. Wolf MT, Hildebrandt F. Nephronophthisis. Pediatr Nephrol 26: 181-194, 2011.
68. Zittema D, Boertien WE, van Beek AP, Dullaart RP, Franssen CF, de Jong PE, Meijer E, Gansevoort RT. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment. Clin J Am Soc Nephrol 7: 906-913, 2012.